CHRONIC HEPATITIS D INFECTION
Clinical trials for CHRONIC HEPATITIS D INFECTION explained in plain language.
Never miss a new study
Get alerted when new CHRONIC HEPATITIS D INFECTION trials appear
Sign up with your email to follow new studies for CHRONIC HEPATITIS D INFECTION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug bulevirtide tracked in real-world hepatitis d patients
Disease control OngoingThis study follows 170 people with chronic hepatitis D who are taking the medication bulevirtide. Researchers want to see how well the drug works over the long term and what side effects may occur. The main focus is on serious liver problems like liver failure, liver cancer, or n…
Matched conditions: CHRONIC HEPATITIS D INFECTION
Sponsor: Gilead Sciences • Aim: Disease control
Last updated May 15, 2026 11:53 UTC
-
New hope for rare liver disease: experimental drug shows promise
Disease control OngoingThis study tests a new medicine called BJT-778 for people with chronic hepatitis delta, a serious liver infection. About 150 adults will either start the drug right away or wait 24 weeks before starting it. The goal is to see if the drug can lower the virus level and improve live…
Matched conditions: CHRONIC HEPATITIS D INFECTION
Phase: PHASE2, PHASE3 • Sponsor: Mirum Pharmaceuticals, Inc. • Aim: Disease control
Last updated May 13, 2026 15:58 UTC